At the ASCO Annual Meeting (May 31 – June 4, 2019; Chicago, IL), Journal of Clinical Pathways sat down with Ali McBride, PharmD, MS, BCOP, FASHP, FAzPA, president of ACCC, to discuss his goals for his presidency, the common ground between standardized care and patient-centered care, and the role of biosimilars in treating patients with cancer in the immediate future.
To read the transcript of this podcast, click here.
